We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.63 | -6.60% | 8.92 | 9.10 | 9.50 | 9.55 | 9.30 | 9.55 | 186,473 | 16:35:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.21 | 86.29M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/5/2018 09:37 | Loz I don't need to lie .. The science is that good nobody yet has questioned it, that i could not reason against you certainly cannot, but its all about effect Posting by YOU will not affect the share price ... You cannot affect it financially, hence you have may feel you have a purpose, but your the only one that considers the posts useful ...lets call it mirror posting .. as your looking back at yourself as "we" | inanaco | |
08/5/2018 09:36 | Ineptico, hahaha, you really are very very desperate aren't you. So a while ago i didn't have any shares at all - then i had some but i had sold them - then i have some, but not very many - now i have shares but cant afford the 12p per share to buy the extra's... hahaha Just how many alter ego's exist, because im losing track.. One thing is for sure though, all of them are still deep in the mire, and way out of the money on their single stock portfolio. If i would have wanted more, i would have bought more, at UNDER 12p , but like over 50% of other PI's, i didnt want any more... Simple. You are so desperate to try and get an average that is anywhere near the current share price that you had no option other than to buy... some of us didn't... we have options, you dont . | tosh123 | |
08/5/2018 09:30 | nanEGO - So...*WE ALL* are left with the OBVIOUS question = Were YOU LYING in the past ??? OR Are YOU LYING now ??? or BOTH ??? | the real lozan | |
08/5/2018 09:29 | Loz you didn't LOL your the only poster i know who has nothing invested .. instead buys wood as a holding commodity | inanaco | |
08/5/2018 09:24 | BoB - One might - for balance - say that = "Don't forget that many of the funds holding SCLP couldn't take part." Cos they got-in {filled-their boots } at 10p | the real lozan | |
08/5/2018 09:22 | Boom Lets not forget Tosh could not afford to take up his full allowance blaming "quota reached" LOL Loz got NO allowance ... apart from his state pension | inanaco | |
08/5/2018 09:19 | Tosh, Don't forget that many of the funds holding SCLP couldn't take part. So that reduces the pool to perhaps around 80%. On that basis a 60% uptake is perfectly reasonable given the share price performance of the Company. The most important point is that Scancell now have funds for SCIB1 and Modi1 trials and will now enter a new phase in their development. Thank goodness, it's been a long time coming. | bermudashorts | |
08/5/2018 09:17 | REALITY in 'perspective' - Dr Sally Adams {SCLP Executive DIRECTOR} has been 'prepared' to 'stump-up' £ 372 towards the 12p OO. The LOSS BOSS {trHYPE DIRECTOR} has HAD to 'stump-up' £3,600 ... JUST to stay where HE was { Not forgetting being DILUTED by circa 20% } . As previously pointed-out = "A FOOL and HIS money....." | the real lozan | |
08/5/2018 08:55 | Exactly... far from being a glowing display of support, it shows that well over 40% of current PI shareholders did not participate in the offering. I say well over 40%, because the 60.1% quoted will include the additional shares that those people who asked for extra shares opted for, which by default means that most shareholders let their options lapse. | tosh123 | |
08/5/2018 08:54 | Terror, all of the investors on LSE got their extras which would suggest at least 50% of legible shareholders took none. | panama7 | |
08/5/2018 08:23 | Foolham and friends on the MFF appear to think the OO was a resounding success. The ASTUTE will observe that 39.1% of the eligible shareholders failed to take up the offer. Providing a balanced perspective is not available via the MFF. | terror | |
06/5/2018 13:34 | The 'We are CASH RICH" anthem - Having apparently 'gotten-over' their 'unhappy feelings' towards the 12p OO and dilution, the 'rallying call' is to point-out ="We are CASH RICH". However, it will not escape the WISER, more ASTUTE... that - although "CASH RICH" { at a price} there are/IS the 'small matter'.. that much of those FUNDS IN HAND.. are already 'ear-marked' for 'declared FUTURE USE'. Lengthy trials WILL COST... in time AND money A long time before 'trial results' will have any REAL bearing ??? The 'simple view' of 'CASH RICH"... is NOT as straight-forward as it may appear.... Some might already be beginning to 'wonder' about the NEXT round of FUND RAISING ??? . Of course, the trHYPE SCAM 'GROUP" will CLAIM...AGAIN = "FUNDING is NOT an ISSUE here" | the real lozan | |
06/5/2018 10:55 | The REALITY of the OO - Once again, *WE ALL* CAN see, just how 'fickle' the M F F F posters are. The 'limited LOUDS'... who were 'backing' the 'wayward' "FUNDING is NOT an ISSUE here" Then 'switched' to the FAKE - "We all knew".. that FUNDING WAS a REALITY / "On the CARDS"... don't seem to be able to make-up their minds. MANY posters/shareholders were indicating, that they were NOT prepared to 'stump-up' more cash - by NOT taking-up their OO allocation. This sees the 'usual voices' having to state, that - ALTHOUGH 'unhappy' to have been forced into the situation - They [few in number} HAVE taken-up their 'cut-price 12p offer'. WHAT DOES THIS INDICATE ??? MAYBE - FINALLY- That enough 'BAD counSEL' is COSTLY enough Those posters/shareholders who 'report' {and the MANY,MANY who don't 'report'}..they are NOT willing to 'stump-up' at this moment-in-time.. are not 'turning-their-backs However It is more than CLEAR, that by showing a 'reluctance towards the 12p OO'...This DOES represent, that - MANY,MANY have/ are... turned their backs on the "GO ALL IN","NO RISK here", BUY,BUY,BUY and HOLD LOSSES... misleading trHYPE 'GROUP'. Reluctance to BUY,BUY,BUY = A HUGE vote of 'NO CONfidence' in the trHYPE 'GROUP' *WE ALL* will have to see the results of the 12p OO... as to 'how many were 'taken-up' ' | the real lozan | |
03/5/2018 15:29 | The guy is a buffoon. A horrible insignificant little man with an ego problem. | tosh123 | |
03/5/2018 15:07 | Wise words Tosh. Every share has an element of risk especially an AIM bio via dilution or failed results. SO Astute way is with Freebies OR money you can afford to lose.So wise to limit your downside AND gain from upside. The IDIOT says ALL in on One AIM share as NO risk.Totally BONKERS whatever he believes in his tiny mind. | drdobson1 | |
03/5/2018 15:04 | DRD - bizarre as ever . . . BTW something is wrong with your keyboard and what is 'HerbertLife' ? DJT59 thank you for the only sane post here today - good reading. ATB | torquayfan | |
03/5/2018 13:34 | DrD, you do make me smile. Great post and good luck. FYI I only took up a portion of my OO allocation, i let some lapse because i dont really want any more shares in this, i have my quota. Lets hope that at some stage over the next 18 months or so, we will see some meaningful share price movement. | tosh123 | |
03/5/2018 13:19 | Had a cheek top up at less than the OO price.I know it is hardly worth the money but just wanted to slap the Village IDIott with a wet fish for HIM getting it SO wrong again. I know it will prove an A$Tute buy as I follow the folk here rather than t other place. Don’t mind others on LSe but luv it when Ineptico takes a good kicking. Back to the Herbalife roundBout | drdobson1 | |
03/5/2018 12:25 | * LOZAN's VIEW *...'T' shirts - Even MORE odd Just been 'informed' that I CAN'T have =* "£6 a share in 18 months" *... displayed on the back of my 'T' shirts... as this is 'copyright' owned by 'FALSE CLAIMS ink'... who 'specialise exclusively' in owning FALSE CLAIMS. | the real lozan | |
03/5/2018 12:14 | * LOZAN'S VIEW *...'T' shirts - How odd Just had an enquiry from a certain *Chip-in Leisurewear* ... wanting to know = What 'Preferential discount' he can have, for buying in BULK ??? | the real lozan | |
03/5/2018 11:44 | Not sure that they are allowed to wear anything other than prison issues Lozan. He may be able to wear it on the prison farm though. | tosh123 | |
03/5/2018 11:33 | LOSS MAKER - Just sitting here, gazing out at the 'panorama' and thinking = I might take a photo, and have some 'T' shirts made, with my 'vista'...printed, in colour of course, with the BOLD words =*LOZAN'S VIEW*... displayed on the front. AND * "£6 a share in 18 months" *... displayed on the back of my 'T' shirts . What do YOU think ??? Would YOU like me to send YOU one ??? | the real lozan | |
03/5/2018 10:37 | from Oxford Tech 2 VCT (OXH) Annual Financial out today: "After the year end, OT2 invested GBP150,000 into Scancell Holdings Plc (Scancell) an AIM-listed stock well known to the Directors and Investment Adviser. ... " Current OXH assets are approx £1.7m, so that is 10% of the fund now (previously OXH was (I think) the only one of the four VCTs that didn't hold Scancell). Actually, OXH has been busier than usual as sold OC Robotics, paid dividend, bought back shares and topped-up a couple of medical investments. And FR continues: " ... Scancell is developing novel immunotherapies for cancer based on two platform technologies known as Immunobody and Moditope. Results from Scancell's first clinical trial for the treatment of melanoma continue to be excellent with recurrence free survival at 69% at 5 years, surpassing results in other trials of ipilimumab (leading immunotherapy for cancer) which showed 46.5% at 3 years. Possibly the biggest news of the year for Scancell was the decision by Cancer Research UK (CRUK) to conduct a trial of SCIB2 in combination with checkpoint inhibitors. SCIB2 should provide the impetus to the immune system to attack the tumor, and the checkpoint inhibitor will remove the barriers to its action. The study will focus on Non Small Lung Cell Cancer, but the results will have relevance for a range of tumors. The trial will be conducted in full by CRUK and Scancell will be able to purchase the results and commercialise them itself, or leave them with CRUK and share in their commercial success. Scancell has also started a development project with BioNtech, the largest privately owned Biotech company in Europe. Scancell's focus is now on generating clinical data and two more trials should read out over the next two years. If Scancell is successful in its CRUK Grand Challenge application it will also be able to start a third trial on Moditope. Scancell has now been granted the European patent for use of citrullinated proteins in cancer treatment. Scancell will use the proceeds of the placing and open offer to support clinical trials for SCIB1, SCIB2 and Modi-1 and pre-clinical work for Modi-2 | djt59 | |
03/5/2018 07:25 | Ineptico, why the continual fantasies about what other people have ? You're clearly a very fragile little man, that needs to try and feel important or superior to others in order to try and compensate for his own inadequacies. Of course, as anyone with the slightest modicum of intelligence will know by now, you've been proven to be a LIAR and a CHEAT and a despicable LOW LIFE, so the chance of you ever really feeling better about yourself, are pretty much zero. | tosh123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions